SRC
ATRS

Shufro Rose & Co’s Antares Pharma, Inc. ATRS Stock Holding History

Shufro Rose & Co’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,000
Closed -$41K – 349
2022
Q1 		$41K Buy
+10,000
New +$36.3K ﹤0.01% 327

Other funds holding ATRS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Shufro Rose & Co's ATRS Position: Q2 2022 in Review

Shufro Rose & Co sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 10,000 shares — an estimated $41K sold.

Shufro Rose & Co first reported a position in ATRS in Q1 2022 and held it in 1 quarter. The position peaked at $41K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

  • Shufro Rose & Co reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
  • Shufro Rose & Co sold 10,000 Antares Pharma, Inc. shares in Q2 2022, an estimated $41K.
  • Shufro Rose & Co first reported a position in Antares Pharma, Inc. in Q1 2022 and held it in 1 quarter.
  • Shufro Rose & Co's Antares Pharma, Inc. position peaked at $41K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Shufro Rose & Co's 13F filing for Q2 2022, filed 22 Jul 2022.